Dr. Tanja Peters currently serves as Deputy EU-QPPV & Head PV Intelligence at Boehringer Ingelheim. She is a physician, with a doctorate in experimental pharmacology and board-certification in clinical pharmacology. Tanja has over 18 years of experience in pharmaceutical industry holding various positions in drug development, regulatory affairs, and pharmacovigilance. Recent projects include leading the implementation of the European Guideline on Good Pharmacovigilance Practices and the setup of an intelligence service specifically dedicated to support sourcing and analysis of new pharmacovigilance relevant regulatory information from worldwide, timely communication to customers and stakeholder, and supporting implementation of new pharmacovigilance requirements.